Clinical Trial Update: R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 trial evaluating first-line R-CHOP in combination with lenalidomide for diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)
• R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: COMPLETED